Target Audience
- Researchers and professionals interested in emerging genome-editing technologies beyond CRISPR-Cas9 and their potential applications in crop and livestock improvement.
- Readers interested in personalized medicine, gene therapy, and drug discovery, particularly the development of compact and precise genome-editing and gene-regulation technologies.
- Anyone seeking a systematic understanding of the evolution of RNA-guided DNA-targeting systems and the latest research developments from 2025 to 2026.
Summary
- TIGR-Tas, reported in Science in 2025, represents a new family of RNA-guided DNA-targeting systems with structural features distinct from those of CRISPR-Cas and OMEGA.
- Its defining characteristics include the recognition of both DNA strands using two spacers within a single guide RNA, the absence of a requirement for a target-adjacent motif in the systems examined, and a modular architecture separating DNA recognition from catalytic activity.
- The structural relationships between TIGR-Tas, IS110 bridge RNA systems, and box C/D snoRNPs provide new insights into the evolutionary origins and diversity of RNA-guided systems.
- Research published in 2026 has further clarified the DNA-cleavage mechanism of TasH and demonstrated applications such as TIGRa, which can simultaneously activate up to 12 genes.
- Although TIGR-Tas is not yet a mature genome-editing platform, it offers promising opportunities for the development of compact and multifunctional genetic engineering technologies relevant to crop improvement, personalized medicine, and drug discovery.
1. What Is TIGR-Tas?
In 2025, Faure, Saito, Wilkinson, and colleagues published a paper in Science titled "TIGR-Tas: A family of modular RNA-guided DNA-targeting systems in prokaryotes and their viruses" [1].
This study identified a previously underexplored family of RNA-guided DNA-targeting systems found in bacteriophages, parasitic bacteria, and related organisms.
These systems consist of Tandem Interspaced Guide RNA (TIGR) and TIGR-associated proteins (Tas), collectively referred to as TIGR-Tas.
Historically, CRISPR-Cas9 and Cas12 have been the best-known technologies for recognizing and manipulating specific DNA sequences using RNA guides.
However, recent discoveries have revealed that nature contains a much broader diversity of RNA-guided systems, including IscB, TnpB, Fanzor, and IS110 bridge RNA systems [2][3][4][5].
TIGR-Tas represents an important addition to this expanding field.
Its significance lies not simply in the discovery of another DNA-cleaving enzyme, but in the identification of a distinct DNA-recognition mechanism and a modular architecture that allows different functional components to be combined.
2. A Brief History of RNA-Guided DNA-Targeting Research
To understand the significance of TIGR-Tas, it is useful to examine the research developments that began with CRISPR-Cas9.
2.1. 2012–2015: Establishing the Fundamental Principles of CRISPR-Cas9
In 2012, Jinek and colleagues demonstrated that Cas9 could be programmed to cleave specific DNA sequences using guide RNAs [2].
In 2013, this principle was extended to genome editing in mammalian cells.
Subsequently, additional RNA-guided nucleases belonging to distinct evolutionary lineages, such as Cas12a (Cpf1), were discovered.
These studies established a fundamental technological principle: a DNA target can be specified by changing the sequence of a guide RNA.
This concept has transformed research in gene function, crop improvement, disease biology, and gene therapy.
However, many CRISPR-Cas systems have relatively large protein components and require specific DNA sequences adjacent to the target, known as protospacer adjacent motifs (PAMs).
These constraints have motivated the search for smaller RNA-guided systems with fewer restrictions on target selection.
2.2. 2021: The Discovery of OMEGA and the Evolutionary Origins of CRISPR
In 2021, Altae-Tran and colleagues reported RNA-guided systems encoded by transposons, including IscB, TnpB, and IsrB [3].
These systems were collectively described as OMEGA, standing for Obligate Mobile Element Guided Activity.
The significance of OMEGA lies in the insights it provides into the evolutionary origins of CRISPR-Cas systems.
Current evidence strongly supports the following evolutionary relationships:
- IscB is closely related to the evolutionary ancestors of Cas9.
- TnpB is closely related to the evolutionary ancestors of Cas12.
- These systems are associated with mobile genetic elements (MGEs), including transposons.
IscB and TnpB use guide RNAs known as ωRNAs to recognize DNA targets.
Their discovery strongly supported the hypothesis that RNA-guided DNA-cleavage mechanisms in CRISPR-Cas systems evolved from machinery originally associated with mobile genetic elements.
In other words, rather than inventing RNA-guided DNA targeting from scratch, CRISPR-Cas systems appear to have acquired and adapted pre-existing molecular mechanisms for use in adaptive immunity.
2.3. 2023: Fanzor Extends RNA-Guided DNA Targeting to Eukaryotes
In 2023, Saito and colleagues demonstrated that Fanzor is an RNA-guided DNA endonuclease found in eukaryotes [4].
Fanzor is evolutionarily related to TnpB.
Previously, research on CRISPR-Cas and OMEGA systems had focused primarily on bacterial and archaeal systems.
The discovery of Fanzor demonstrated that related RNA-guided nucleases also exist in eukaryotes and their mobile genetic elements.
Furthermore, Fanzor was shown to support genome editing in human cells.
This discovery provided important evidence that RNA-guided DNA-targeting mechanisms are distributed across a much broader range of biological systems than previously appreciated.
2.4. 2024: IS110 Bridge RNA Introduces a New Principle of DNA Manipulation
In 2024, researchers discovered the bridge RNA (bRNA) mechanism used by IS110-family transposons [5][6].
Unlike CRISPR-Cas9, which primarily functions as a programmable DNA nuclease, this system mediates recombination between two DNA molecules.
Bridge RNA contains two major DNA-recognition regions:
- Target-binding loop: Recognizes the target DNA sequence.
- Donor-binding loop: Recognizes the DNA molecule to be inserted.
By modifying these regions, researchers can program recombination between selected target and donor DNA sequences.
This mechanism has potential applications in DNA insertion, excision, and inversion.
Its importance lies in demonstrating that RNA-guided systems are not limited to DNA cleavage; they can also direct DNA recombination.
IS110 bridge RNA systems are particularly relevant to TIGR-Tas because of their structural and possible evolutionary relationships.
2.5. 2025: TIGR-Tas Reveals a New DNA-Recognition Principle
The TIGR-Tas study published in 2025 [1] extended this research trajectory further.
TIGR-Tas has structural features distinct from those of CRISPR-Cas and OMEGA and recognizes both strands of a DNA duplex using two RNA spacers.
The study also identified structural similarities between TIGR-Tas, IS110 bridge RNA systems, and box C/D snoRNPs.
These findings suggest that RNA-guided DNA-targeting systems may have more diverse evolutionary origins and mechanisms than previously recognized.
3. Evolutionary Relationships Among CRISPR-Cas9, IscB, TnpB, Fanzor, IS110, and TIGR-Tas
The relationships among these systems can be summarized schematically.
Importantly, the following diagram is not intended to represent a fully established phylogenetic tree in which all systems diverged sequentially from a single known ancestor.
It is necessary to distinguish strongly supported evolutionary relationships from relationships inferred primarily through structural similarities.
3.1. Schematic Overview of Evolutionary Relationships
RNA-Guided Nucleic Acid Recognition and Manipulation
│
├── A. OMEGA / CRISPR-Related Lineages
│ │
│ ├── IscB
│ │ │
│ │ └── → CRISPR-Cas9
│ │ (Adaptive immunity,
│ │ DNA cleavage, genome editing)
│ │
│ └── TnpB
│ │
│ ├── → CRISPR-Cas12
│ │ (Adaptive immunity, DNA cleavage)
│ │
│ └── → Fanzor
│ (Eukaryotic RNA-guided DNA cleavage)
│
└── B. Nop-Domain-Related RNA-Guided RNP Systems
│
├── TIGR-Tas
│ │
│ ├── TasA
│ │ (DNA recognition, no nuclease domain)
│ │
│ ├── TasH
│ │ (HNH nuclease)
│ │
│ └── TasR
│ (RuvC nuclease)
│
├── IS110 Bridge RNA System
│ (RNA-guided DNA recombination)
│
└── Box C/D snoRNP
(RNA recognition and modification)
Notes:
- The precise ancestor-descendant relationships
among the three systems in group B
remain unresolved.
- Group B illustrates structural and functional
relationships, not a definitive phylogeny.In this diagram, groups A and B are separated for conceptual clarity. This does not mean that the two groups necessarily evolved in complete isolation.
Within group A, strong evidence supports evolutionary relationships connecting IscB with Cas9 and TnpB with Cas12. Fanzor is also evolutionarily related to TnpB [3][4].
In group B, TIGR-Tas, IS110 bridge RNA systems, and box C/D snoRNPs share structural similarities [1][6].
However, the precise order of their evolutionary divergence and the identity of their direct ancestors remain uncertain.
3.2. Functional Overview of RNA-Guided Systems
The functional differences among these systems can be summarized separately from their evolutionary relationships.
RNA-Guided Nucleic Acid Recognition
│
┌──────────────┼──────────────┐
│ │ │
DNA Cleavage DNA Recombination RNA Modification
│ │ │
┌──────┴──────┐ │ │
│ │ │ │
CRISPR-Cas OMEGA IS110 Box C/D
9 / 12 │ Bridge RNA snoRNP
│ │
│ ┌─────┴─────┐
│ │ │
│ IscB TnpB
│ │
│ Fanzor
│
│
└──────── TIGR-Tas ─────────┐
│
RNA-Guided DNA
Recognition
│
┌───────┼───────┐
│ │ │
TasA TasH TasR
│ │ │
DNA Binding HNH RuvC
Cleavage CleavageThis diagram illustrates functional relationships rather than evolutionary branching.
A defining feature of TIGR-Tas is that it combines RNA-guided DNA recognition with different nuclease modules [1].
This modular architecture distinguishes TIGR-Tas from many other RNA-guided systems.
4. The Defining Feature of TIGR-Tas: Dual-Spacer Recognition of Both DNA Strands
4.1. How TIGR-Tas Differs from Conventional CRISPR-Cas9
In conventional CRISPR-Cas9, the spacer region of a guide RNA forms base pairs with one strand of the target DNA.
The other DNA strand is displaced, producing a structure known as an R-loop.
In contrast, TIGR-Tas uses a guide RNA called tigRNA, which contains two spacer regions [1].
- Spacer A recognizes one strand of the DNA duplex.
- Spacer B recognizes the opposite DNA strand.
This enables the system to recognize target DNA using two RNA-DNA heteroduplexes.
The mechanism differs substantially from the DNA-recognition mechanisms employed by conventional Cas9 and Cas12 systems.
4.2. Schematic Comparison of DNA-Recognition Mechanisms
[CRISPR-Cas9]
Guide RNA
│
└──────────────┐
│
DNA Strand 1 ─────────────────────
|||||||||
DNA Strand 2 ─────────────────────
│
Cas9
│
DNA Cleavage
Key features:
- RNA base-pairs primarily with one DNA strand
- R-loop formation
- PAM requirement
[TIGR-Tas]
tigRNA
┌────────────┐
│ │
Spacer A Spacer B
│ │
▼ ▼
DNA Strand 1 ────────╲ ╱────────
||||
RNA-DNA
Pairing
||||
DNA Strand 2 ────────╱ ╲────────
Tas Dimer
│
┌───────┼───────┐
│ │ │
TasA TasH TasR
│ │ │
DNA HNH RuvC
Binding Cleavage Cleavage
Key features:
- Two spacers recognize opposite DNA strands
- No PAM/TAM-like adjacent motif required
in the systems examined
- Modular DNA-recognition and cleavage functionsNote: These diagrams are conceptual illustrations and do not reproduce the precise three-dimensional structures or spatial arrangements of the DNA strands and protein complexes.
4.3. Why PAM-Independent Targeting Matters
Many Cas9 and Cas12 systems require specific nucleotide sequences adjacent to their target sites.
These sequences are known as PAMs in CRISPR systems and target-adjacent motifs (TAMs) in OMEGA systems.
Such requirements restrict the DNA sequences that can be targeted.
In the TIGR-Tas systems examined, no equivalent PAM- or TAM-like target-adjacent motif was required [1].
This property could potentially broaden the range of DNA sequences available for applications in crop improvement and gene therapy.
However, the absence of a PAM requirement does not mean that all DNA sequences can be targeted with equal efficiency or that off-target effects are absent.
Practical applications will require careful evaluation of sequence dependence, DNA structure, cellular activity, and off-target effects.
5. The Modular Architecture of TIGR-Tas
Another important feature of TIGR-Tas is its modular protein architecture.
Tas proteins are compact proteins of approximately 300 amino acids and contain a central Nop (nucleolar protein) domain [1].
Different types of Tas proteins contain distinct nuclease domains attached to this shared structural framework.
| System | Major Domains | Functional Characteristics |
|---|---|---|
| TasA | Nop domain | DNA recognition without a nuclease domain |
| TasH | Nop + HNH | RNA-guided DNA cleavage |
| TasR | Nop + RuvC | RNA-guided DNA cleavage |
This architecture suggests the following general design principle.
tigRNA-Guided DNA Recognition
│
▼
Nop-Domain Recognition
│
┌────────┼────────┐
│ │ │
TasA TasH TasR
│ │ │
DNA HNH RuvC
Binding Cleavage CleavageIn other words, DNA recognition and the enzymatic reactions that follow are organized into relatively independent functional modules.
This design differs from that of Cas9, which functions as an integrated nuclease system.
In the future, the modular architecture of TIGR-Tas may make it possible to engineer artificial RNA-guided systems with different functions, including DNA cleavage, DNA binding, and transcriptional regulation.
Indeed, a transcriptional activation system called TIGRa, based on TasR, was reported in 2026 [9].
6. Evolutionary Relationships Among TIGR-Tas, IS110, and Box C/D snoRNPs
One of the most significant findings of the TIGR-Tas study from a fundamental biological perspective is the structural similarity between TIGR-Tas, IS110 bridge RNA systems, and box C/D snoRNPs [1].
6.1. What Are Box C/D snoRNPs?
Box C/D snoRNPs are ribonucleoprotein complexes that use guide RNAs to recognize target RNAs and primarily direct 2'-O-methylation of RNA.
These systems are involved in processes such as ribosomal RNA modification.
Traditionally, box C/D snoRNPs have been studied as RNA-targeting systems.
TIGR-Tas, by contrast, targets DNA.
As a result, these systems have historically been investigated in largely separate areas of molecular biology.
6.2. Shared Nop-Domain RNP Architecture
Faure and colleagues demonstrated that the three-dimensional structure of TasR resembles the structures of box C/D snoRNPs and IS110 RNA-guided transposases [1].
They also showed that box C/D motifs within tigRNA are involved in interactions with the Nop domain of Tas proteins.
These similarities suggest that RNA-guided DNA targeting and RNA-guided RNA modification may have evolved from related ancient ribonucleoprotein architectures.
Their functional characteristics can be compared as follows.
| System | Guide Molecule | Primary Target | Main Function |
|---|---|---|---|
| Box C/D snoRNP | snoRNA | RNA | RNA 2'-O-methylation |
| IS110 bridge RNA | bRNA | Target and donor DNA | DNA recombination |
| TIGR-Tas | tigRNA | Both DNA strands | DNA recognition and cleavage |
6.3. Why Are These Evolutionary Relationships Important?
The importance of this finding is that RNA-guided nucleic acid recognition may have been adapted for a wider variety of biological functions than previously appreciated.
For example, an ancient RNA-recognition mechanism based on Nop-domain proteins may have acquired different enzymatic capabilities through the fusion of additional catalytic domains.
This could have contributed to the evolution of functions such as DNA cleavage and DNA recombination.
The original TIGR-Tas paper discusses the possibility that nuclease-free TasA represents a relatively ancestral form and that HNH and RuvC domains were independently acquired through domain fusion.
The authors also propose that TasR may represent an intermediate evolutionary configuration linking TIGR-Tas and box C/D snoRNPs.
However, these remain evolutionary hypotheses.
It has not been established that TIGR-Tas is the direct ancestor of IS110 or box C/D snoRNP systems.
At present, it is important to distinguish the discovery of structural similarities from the definitive reconstruction of evolutionary pathways.
7. Advances in TIGR-Tas Research Through 2026
Since the original TIGR-Tas paper was published in 2025, research on this family of systems has progressed rapidly.
Studies reported in 2026 have provided deeper insights into DNA recognition and cleavage mechanisms, as well as potential applications in gene regulation.
7.1. Understanding the DNA-Cleavage Mechanism of TasH
In 2026, Yang and colleagues published "Molecular basis for dual-spacer-guided target cleavage by the TIGR-TasH system" in Molecular Cell [7].
This study analyzed six cryo-electron microscopy structures of a TIGR-TasH complex derived from a Salicola phage.
The researchers identified several important mechanistic features:
- The coiled-coil region of TasH contributes to dimer formation.
- The Nop domain can autonomously process precursor tigRNA.
- The HNH nuclease domain is positioned at the cleavage site following target recognition.
- A β-hairpin contributes to HNH-domain positioning and target selection.
- The box C motif of tigRNA contributes to stabilization of the complex.
Furthermore, the researchers demonstrated that modifications to tigRNA could produce programmable nickases capable of selectively cleaving one strand of DNA rather than generating a double-strand break.
This approach differs from conventional Cas9 nickases, which are generally engineered by introducing mutations into the catalytic domains of the protein.
In TIGR-TasH, the guide RNA itself may provide a means of controlling the DNA-cleavage outcome.
7.2. Asymmetry in Dual-Spacer Target Recognition
In 2026, Guan and colleagues reported a study of TIGR-Tas DNA-recognition mechanisms on bioRxiv [8].
The researchers investigated TasA and TasH to understand the molecular basis of dual-spacer targeting.
Because TIGR-Tas uses two spacers to recognize opposite DNA strands, the system initially appears to operate through a relatively symmetric recognition mechanism.
However, the results suggest that DNA recognition proceeds through a stepwise and asymmetric process.
In the proposed model, initial recognition by Spacer A is followed by additional recognition involving Spacer B and conformational changes in the protein complex.
This coordinated mechanism may allow the system to verify that both DNA strands have been appropriately recognized before activating cleavage.
Such a mechanism could be important for understanding target specificity and DNA-cleavage accuracy.
However, as of October 2026, this study remains a preprint and should be distinguished from findings published in peer-reviewed journals.
7.3. TIGRa Enables Simultaneous Activation of Multiple Genes
In 2026, a study titled "TIGRa: An ultra-compact programmable activator enabling multiplexed and efficient gene regulation" was published in Cell Stem Cell [9].
The researchers developed TIGRa, a transcriptional activation system based on the DNA-recognition capabilities of TasR.
Rather than cleaving DNA, TIGRa activates the expression of targeted genes.
Its purpose is similar to that of CRISPR activation systems, or CRISPRa, but it employs a distinct DNA-recognition mechanism derived from TIGR-Tas.
Several findings are particularly important:
- TIGRa was engineered to be less than half the size of a dSpCas9-based transcriptional activation system.
- The TIGR array architecture enabled simultaneous activation of up to 12 endogenous genes from a single compact construct.
- The system was used to reprogram human fibroblasts into induced pluripotent stem cells (iPSCs).
- Delivery using a single adeno-associated virus (AAV) vector was demonstrated.
- In a mouse model of retinal injury, the system showed effects related to retinal ganglion cell survival and preservation of visual function.
This research demonstrates that TIGR-Tas can be developed not only as a DNA-cleavage system but also as a platform for controlling gene expression.
For personalized medicine and drug discovery, the ability to regulate multiple genes simultaneously is particularly important.
8. Comparing TIGR-Tas with Other RNA-Guided Systems
A comparison of major RNA-guided systems highlights the distinctive characteristics of TIGR-Tas.
| System | Natural Occurrence or Context | RNA-Guided Recognition | Adjacent Motif | Main Function | Relationship to TIGR-Tas |
|---|---|---|---|---|---|
| CRISPR-Cas9 | Bacterial and archaeal adaptive immunity | Base-pairing primarily with one DNA strand | PAM | DNA cleavage | Established genome-editing platform |
| CRISPR-Cas12 | Bacterial and archaeal adaptive immunity | Base-pairing primarily with one DNA strand | PAM | DNA cleavage | Evolutionarily related to TnpB |
| IscB | Transposons | ωRNA-guided DNA recognition | TAM | DNA cleavage | Closely related to the evolutionary ancestors of Cas9 |
| TnpB | Transposons | ωRNA-guided DNA recognition | TAM | DNA cleavage | Closely related to the evolutionary ancestors of Cas12 |
| Fanzor | Eukaryotic mobile genetic elements and related contexts | ωRNA-guided DNA recognition | TAM-like sequence | DNA cleavage | Evolutionarily related to TnpB |
| IS110 bridge RNA | Transposons | Recognition of target and donor DNA | System-specific sequence requirements | DNA recombination | Structurally related to TIGR-Tas |
| TIGR-Tas | Bacteriophages, archaeal viruses, parasitic bacteria, and related organisms | Two spacers recognize opposite DNA strands | Not required in the systems examined | DNA recognition, cleavage, and applications in transcriptional regulation | Distinct Nop-domain-based modular architecture |
These characteristics are based on studies of CRISPR/OMEGA, Fanzor, bridge RNA, and TIGR-Tas systems [1][3][4][5][6].
This comparison illustrates that research on RNA-guided systems is not simply focused on discovering DNA-cleaving enzymes that outperform Cas9.
Instead, the field is expanding toward diverse platforms capable of DNA cleavage, recombination, and gene-expression regulation.
9. Comparison with Related Research Published in 2025–2026
To evaluate the future potential of TIGR-Tas, it is useful to compare it with recent advances in other compact RNA-guided systems.
9.1. TnpB: Toward Genome Editing in Plants and Human Cells
In 2026, Thornton and colleagues published "Engineered TnpB genome editors for plants and human cells identified by ribonucleoprotein mutational scanning" in Nature Biotechnology [10].
In this study, the researchers performed large-scale mutational analysis of TnpB proteins and guide RNAs to identify variants with improved DNA-cleavage and genome-editing activities.
The engineered variants were evaluated in human cells and several plant systems, including Nicotiana species, pepper, and rice.
In Nicotiana benthamiana, insertion/deletion (indel) frequencies of up to 55% were reported, representing approximately a 50-fold improvement over the wild-type system.
These results demonstrate the potential of compact RNA-guided nucleases for crop improvement.
In comparison, similarly extensive enzyme engineering and performance evaluation in plants have not yet been established for TIGR-Tas.
Therefore, from the perspective of practical applications in crop improvement, engineered TnpB currently has a stronger experimental track record.
Nevertheless, the absence of a target-adjacent motif requirement and the dual-spacer recognition mechanism of TIGR-Tas may provide different technological advantages in the future.
9.2. Fanzor: Development as a Compact Genome-Editing Platform
In 2025, Zhao and colleagues published "Engineered hypercompact Fanzor-ωRNA system with enhanced genome editing activity" in Molecular Cell [11].
This study developed an engineered Fanzor variant, SpuFz1 V4, with enhanced DNA-cleavage activity.
The researchers also demonstrated the use of Fanzor as a base-editing platform through fusion with DNA deaminases, enabling targeted adenine and cytosine editing.
Furthermore, its compact size enabled delivery using a single AAV vector and in vivo genome editing in the retina.
These findings represent important progress toward therapeutic applications of compact RNA-guided DNA-cleavage systems.
TIGR-Tas is also compact, and AAV-based delivery has been demonstrated for gene-regulation applications.
However, as a DNA-cleavage-based genome-editing platform, TIGR-Tas has not yet reached the same stage of development as engineered Fanzor systems.
9.3. IS110 Bridge RNA: Toward Insertion of Large DNA Fragments
Research published in 2026 also advanced the use of IS110 bridge RNA systems for inserting large DNA fragments into human cells [12].
A study in Nature Communications reported the development of an engineered IS621 recombinase and bridge RNA system known as enIS621-tebRNA.
This system enabled targeted insertion of kilobase-scale DNA fragments into specific genomic regions in human cells.
Under certain experimental conditions, DNA integration efficiencies of up to 27.75% were reported.
The study also examined the insertion of genes relevant to therapeutic applications, including a CD19 chimeric antigen receptor (CAR) gene associated with CAR-T cell therapy and a human factor IX gene related to hemophilia B.
These results demonstrate progress toward technologies capable of inserting large genetic sequences at specified genomic locations rather than simply cutting DNA.
In addition, a 2026 Nature study clarified structural mechanisms controlling the directionality of DNA insertion and excision in IS110 bridge recombination [13].
Although IS110 and TIGR-Tas share structural relationships, their current application trajectories differ.
IS110 research is moving toward programmable DNA recombination and large-scale DNA insertion.
TIGR-Tas research is developing toward a modular platform for DNA recognition, cleavage, and transcriptional regulation.
9.4. Research Maturity and Development Trajectories
The research landscape as of October 2026 can be summarized as follows.
| System | Major Research Direction | Demonstrated Achievements | Remaining Challenges |
|---|---|---|---|
| CRISPR-Cas9/Cas12 | Genome editing and gene regulation | Broad applications across diverse cells and organisms | Delivery, off-target effects, editing precision |
| IscB | Compact genome-editing nucleases | Genome editing in human cells | Optimization of activity and specificity |
| TnpB | Compact genome-editing nucleases and crop improvement | Improved editing activity in human and plant cells | Target dependence, stability, delivery |
| Fanzor | Compact genome editing and base editing | Engineered Fanzor variants and single-AAV delivery | Activity, specificity, safety |
| IS110 bridge RNA | DNA insertion, excision, and recombination | Insertion of large DNA fragments in human cells | Efficiency, target selection, safety |
| TIGR-Tas | DNA recognition, cleavage, and transcriptional regulation | Editing in human cells and TIGRa-mediated multiplex gene activation | Editing activity, specificity, validation across diverse cells and organisms |
Based on these developments, the field appears to be diversifying along several directions:
- TnpB, IscB, and Fanzor: Improving the performance of compact RNA-guided nucleases for genome editing.
- IS110 bridge RNA: Developing programmable recombination technologies for manipulating large DNA fragments.
- TIGR-Tas: Developing modular platforms for DNA cleavage, binding, and transcriptional regulation through PAM-independent targeting and dual-spacer recognition.
10. Potential Applications in Crop Improvement, Personalized Medicine, and Drug Discovery
Although TIGR-Tas is fundamentally important from an evolutionary and molecular biology perspective, its distinctive properties may also have implications for future biotechnology applications.
10.1. Potential Applications in Crop Improvement
In crop improvement, genetic manipulation of traits such as yield, disease resistance, environmental stress tolerance, and product quality is particularly important.
Because the TIGR-Tas systems examined do not require PAM- or TAM-like target-adjacent motifs, they may broaden the selection of target DNA sequences available for genetic engineering [1].
The TIGR array architecture may also support multiplex targeting and combinations with functional modules other than nucleases.
However, further research is necessary to evaluate editing efficiency in plant cells, transformation and delivery methods, off-target effects, and genetic stability.
At present, TIGR-Tas remains at an earlier stage of development for crop improvement than engineered TnpB systems, which demonstrated high editing activity in plants in 2026 [10].
10.2. Potential Applications in Personalized Medicine
Personalized medicine aims to tailor treatments to the genetic variants and disease characteristics of individual patients.
The compact size and potentially flexible target selection of TIGR-Tas make it an interesting candidate for future gene-therapy applications.
Importantly, approaches such as TIGRa offer alternatives to direct DNA cleavage by activating the expression of endogenous genes [9].
Such strategies could provide opportunities to regulate cellular states without directly changing the underlying DNA sequence.
Furthermore, the demonstration of single-AAV delivery is an important step toward delivering gene-regulation technologies in vivo.
However, experimental findings in animal models do not automatically establish therapeutic efficacy or safety in humans.
Further evaluation of off-target effects, immune responses, long-term expression, and overall safety will be essential.
10.3. Potential Applications in Drug Discovery
Drug discovery frequently requires understanding gene functions associated with disease and controlling cellular states influenced by multiple genes.
The ability of TIGRa to activate up to 12 genes simultaneously may be useful for such research [9].
For example, coordinated regulation of multiple genes could help researchers study cell differentiation, disease models, and drug responses.
In addition, nuclease-free systems such as TasA may provide a foundation for recruiting functional molecules to specified DNA sequences without directly cleaving DNA.
However, these applications will require further technological development.
TIGR-Tas-based drug development and therapeutic approaches have not yet reached routine clinical or commercial implementation.
11. The Current Position of TIGR-Tas and Future Perspectives
The scientific importance of TIGR-Tas should be evaluated from two distinct perspectives: fundamental biology and applied biotechnology.
11.1. Significance for Fundamental Biology
From the perspective of fundamental biology, TIGR-Tas represents a major discovery.
The identification of OMEGA systems provided important insights into the evolutionary origins of Cas9 and Cas12.
TIGR-Tas extends this understanding by demonstrating the existence of RNA-guided DNA-targeting systems with distinct structural characteristics outside the conventional CRISPR/OMEGA framework.
Furthermore, its structural similarities to IS110 bridge RNA systems and box C/D snoRNPs provide evidence for potentially shared architectural principles across systems involved in DNA cleavage, DNA recombination, and RNA modification.
The Nop-domain-centered RNP architecture, combined with HNH or RuvC nuclease domains, is particularly relevant to understanding how diverse RNA-guided systems may have evolved.
11.2. Maturity as a Genome-Editing Technology
From a technological perspective, TIGR-Tas remains at an early stage of development.
Compared with CRISPR-Cas9 and Cas12, substantially less information is available regarding editing efficiency across different targets, off-target effects, cell-type dependence, in vivo performance, and long-term safety.
Furthermore, engineered TnpB and Fanzor systems have already demonstrated improvements in genome-editing activity, applications in human and plant cells, base editing, and AAV delivery [10][11].
Therefore, TIGR-Tas is unlikely to immediately replace these established or more extensively developed systems.
Nevertheless, TIGR-Tas combines several distinctive features:
- Compact Tas proteins of approximately 300 amino acids.
- No requirement for PAM/TAM-like target-adjacent motifs in the systems examined.
- Recognition of both DNA strands through two RNA spacers.
- Multiplex targeting using natural TIGR array architectures.
- Modular organization of DNA-recognition and nuclease functions.
- Emerging applications beyond DNA cleavage, including gene-expression regulation.
This combination of characteristics creates opportunities for research and development that differ from those of existing genome-editing platforms.
11.3. Key Research Challenges Ahead
Several research priorities are likely to determine the future development of TIGR-Tas:
- Elucidating the detailed mechanism of dual-spacer DNA recognition and its relationship to targeting accuracy.
- Improving DNA-cleavage activity through engineering of Tas proteins and tigRNA.
- Systematically evaluating off-target effects and safety.
- Testing performance in plant cells and diverse human cell types.
- Optimizing delivery technologies, including AAV-based approaches.
- Developing new platforms that combine DNA binding, cleavage, and transcriptional activation.
- Further clarifying evolutionary relationships among TIGR-Tas, IS110 bridge RNA systems, and box C/D snoRNPs.
Progress in these areas should help establish both the fundamental biological significance and the practical technological potential of TIGR-Tas.
11.4. Conclusion: How Should TIGR-Tas Be Positioned?
It would be misleading to view TIGR-Tas simply as a new genome-editing enzyme intended to replace CRISPR-Cas9.
The primary importance of this discovery is that it reveals an additional design principle for RNA-guided DNA targeting, distinct from the conventional CRISPR/OMEGA framework.
Its structural similarities to IS110 bridge RNA systems and box C/D snoRNPs also provide new perspectives on the evolution of RNA-guided molecular machinery.
From an applied perspective, mechanistic studies of TasH and the development of TIGRa in 2026 demonstrate that TIGR-Tas is beginning to evolve from a newly discovered DNA-targeting system into a broader platform for DNA recognition, cleavage, and gene-expression regulation.
Its current scientific position can be summarized as follows:
TIGR-Tas should be understood not merely as the discovery of "the next Cas9," but as the identification of a new modular RNA-guided platform that expands our understanding of the evolutionary diversity of nucleic acid recognition and manipulation.
For crop improvement, personalized medicine, and drug discovery, TIGR-Tas is not yet a direct replacement for existing CRISPR technologies.
Nevertheless, its compact size, flexible target selection, dual-spacer recognition, modular architecture, and multiplex gene-regulation capabilities create opportunities to expand the capabilities of future genetic engineering technologies.
The discovery of TIGR-Tas illustrates an important trend in genome-editing research: progress is being driven not only by engineering existing CRISPR systems, but also by discovering fundamentally different RNA-guided molecular systems that already exist in nature.
References
[1] Faure, G., Saito, M., Wilkinson, M. E., et al., “TIGR-Tas: A family of modular RNA-guided DNA-targeting systems in prokaryotes and their viruses,” Science, 388(6746), eadv9789, 2025. https://doi.org/10.1126/science.adv9789
Full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC12045711/
[2] Jinek, M., Chylinski, K., Fonfara, I., et al., “A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity,” Science, 337(6096), 816–821, 2012. https://doi.org/10.1126/science.1225829
[3] Altae-Tran, H., Kannan, S., Demircioglu, F. E., et al., “The widespread IS200/605 transposon family encodes diverse programmable RNA-guided endonucleases,” Science, 374(6563), 57–65, 2021. https://doi.org/10.1126/science.abj6856
Full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC8929163/
[4] Saito, M., Xu, P., Faure, G., et al., “Fanzor is a eukaryotic programmable RNA-guided endonuclease,” Nature, 620, 660–668, 2023. https://doi.org/10.1038/s41586-023-06356-2
[5] Durrant, M. G., Perry, N. T., Pai, J. J., et al., “Bridge RNAs direct programmable recombination of target and donor DNA,” Nature, 630, 575–583, 2024. https://doi.org/10.1038/s41586-024-07552-4
[6] Hiraizumi, M., Perry, N. T., Durrant, M. G., et al., “Structural mechanism of bridge RNA-guided recombination,” Nature, 630, 994–1002, 2024. https://doi.org/10.1038/s41586-024-07570-2
[7] Yang, J., Wang, T., Liu, Z., et al., “Molecular basis for dual-spacer-guided target cleavage by the TIGR-TasH system,” Molecular Cell, 86(7), 1217–1229.e6, 2026. https://doi.org/10.1016/j.molcel.2026.02.017
[8] Guan, K., Appleby, N. M., Huang, B., et al., “Asymmetric DNA targeting by RNA-guided TIGR-Tas systems,” bioRxiv, preprint, 2026. https://doi.org/10.64898/2026.08.11.744272
Preprint: https://www.biorxiv.org/content/10.64898/2026.08.11.744272v1
[9] “TIGRa: An ultra-compact programmable activator enabling multiplexed and efficient gene regulation,” Cell Stem Cell, 33(9), 1553–1566.e4, 2026. https://doi.org/10.1016/j.stem.2026.07.008
Publication page: https://www.sciencedirect.com/science/article/pii/S1934590926002687
[10] Thornton, B. W., Weissman, R. F., Rodriguez, J. E., et al., “Engineered TnpB genome editors for plants and human cells identified by ribonucleoprotein mutational scanning,” Nature Biotechnology, 2026. https://doi.org/10.1038/s41587-026-03059-7
[11] Zhao, G., Liu, Y., Zhang, G., et al., “Engineered hypercompact Fanzor-ωRNA system with enhanced genome editing activity,” Molecular Cell, 85(22), 4138–4151.e4, 2025. https://doi.org/10.1016/j.molcel.2025.09.031
Publication page: https://www.sciencedirect.com/science/article/abs/pii/S1097276525008160
[12] “Optimization of IS621 recombinase/bridge RNA-directed recombination for precise insertion of large DNA fragments in human cells,” Nature Communications, 17, Article 7234, 2026. https://doi.org/10.1038/s41467-026-74164-z
[13] “Structural mechanism governing the directionality of bridge recombination,” Nature, 2026. https://doi.org/10.1038/s41586-026-10903-y